Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors

Author： Rizzieri David A.   Crout Christopher   Storms Robert   Golob Jared   Long Gwynn D.   Gasparetto Cristina   Sullivan Keith M.   Horwitz Mitchell   Chute John   Lagoo Anand S.   Morris Ashley   Beaven Anne   Yang Yiping   Peterson Bercedis   Li Zhiguo   Chao Nelson J.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.29, Iss.1, 2011-01, pp. : 56-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry

By Spasojevic Ivan   da Costa Ligia R. S.   Horwitz Mitchell E.   Long Gwynn D.   Sullivan Keith M.   Chute John P.   Gasparetto Cristina   Morris Ashley   Chao Nelson J.   Rizzieri David A.  

Cancer Investigation, Vol. 30, Iss. 9, 2012-10 ,pp. : 679-682

Informa Healthcare

Access to resources Recommend Favorite

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results. Rini BI, Zimmerman T, Stadler WM, Gajewski TF, Vogelzang NJ, University of California San Francisco, Comprehensive Cancer Center, San Francisco, CA - J Clin Oncol 2002;20:2017-2024

By Trump D.L.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 5, 2003-09 ,pp. : 412-413

Elsevier

Access to resources Recommend Favorite

The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)

By Bevans Margaret  

Supportive Care in Cancer, Vol. 16, Iss. 11, 2008-11 ,pp. : 1243-1254

Springer Publishing Company

Access to resources Recommend Favorite

Allogeneic hematopoietic stem cell transplantation as the firstline treatment option in a patient with severe aplastic anemia without a matched related donor: A case report

By      

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1831-1833

Spandidos Publications

Access to resources Recommend Favorite

Kaposi's sarcoma developed after allogeneic hematopoietic stem cell transplantation

By Ye Xu   Feng Ying   Pang Ying   Liu Yanhui   Lin Suxia  

Oncology Letters, Vol. 2, Iss. 3, 2011-05 ,pp. : 515-518

Spandidos Publications

Access to resources Recommend Favorite